SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.57-0.8%Nov 3 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doc Bones who wrote (1297)4/11/2002 2:32:42 PM
From: Arthur Radley   of 1475
 
Just listened to the CEO's presentation....sure sounded good for a $3.50 stock.
Upcoming Events..
1)Initiate Siplizumab Phase II PA trials in Q2
2Initiate Siplizumab Phase III for psoriasis2H
3)Initiate Sip. Phase II for RA 2H
4) Initiate Tcell-HDM Phase III trial 2H
5) Additional CE Mark authorization 2H
6) Initiat Allomune Phase II/III lymphoma trial in 2H

2002 will be a busy year!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News